Literature DB >> 32046433

miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma.

Baohua Qiao1, Qingzhi Wang1, Yuying Zhao1, Jingli Wu2.   

Abstract

Ovarian cancer (OC) represents the most lethal form of gynaecologic cancers in developed countries. To develop a better therapeutic against OC, characterizing new classes of molecular regulators such as microRNAs (miRNAs) involved in OC tumorigenesis becomes immensely important. We used human OC cell lines to study the expression pattern of miRNA-205-3p. We then employed miRNA-205-3p mimic and inhibitor to elucidate its functional role in OC cells. Downstream target of miRNA-205-3p was characterized in OC cells with luciferase gene reporter assay and Western blotting. Its functional role in OC was also investigated with the siRNA approach. Lastly, we assessed the expression change of miRNA-205-3p and its newly identified target in human OC tissues. miR-205-3p was downregulated in five human OC lines tested. Over-expressing miR-205-3p reduced OC cell proliferation and migration. MAPK10 was identified as a direct target of miR-205-3p. Knocking down MAPK10 suppressed OC cell growth and migration. In contrast, knocking down miR-205-3p promoted clonogenicity of primary ovary cells. In clinical samples, miR-205-3p and MAPK10 expressed inversely in accordance with their expression patterns in OC cells. miR-205-3p was shown as a novel tumor suppressor in OC via inhibiting the MAPK10 pathway. This new finding may inspire new personalized treatment for OC.

Entities:  

Keywords:  HeyA8; MAPK10; Ovarian cancer; SK-OV-3; miR-205-3p

Mesh:

Substances:

Year:  2020        PMID: 32046433     DOI: 10.1007/s43032-019-00047-y

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  5 in total

1.  CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.

Authors:  Lei Zhang; Yidong Li; Chaohua Hu; Yangmin Chen; Zhuo Chen; Zhe-Sheng Chen; Jian-Ye Zhang; Shuo Fang
Journal:  Mol Cancer       Date:  2022-04-22       Impact factor: 41.444

2.  miR-335-5p suppresses gastric cancer progression by targeting MAPK10.

Authors:  Yi Gao; Yanfeng Wang; Xiaofei Wang; Changan Zhao; Fenghui Wang; Juan Du; Huahua Zhang; Haiyan Shi; Yun Feng; Dan Li; Jing Yan; Yan Yao; Weihong Hu; Ruxin Ding; Mengjie Zhang; Lumin Wang; Chen Huang; Jing Zhang
Journal:  Cancer Cell Int       Date:  2021-01-22       Impact factor: 5.722

3.  Tanshinone IIA Improves Ventricular Remodeling following Cardiac Infarction by Regulating miR-205-3p.

Authors:  Peng Qiao; Jie Xu; Xueni Liu; Xuehan Li
Journal:  Dis Markers       Date:  2021-11-29       Impact factor: 3.434

4.  Bioinformatics analysis of prognostic value and prospective pathway signal of miR-30a in ovarian cancer.

Authors:  Weijia Lu; Yunyu Wu; Can Xiong Lu; Ting Zhu; Zhong Lu Ren; Zhiwu Yu
Journal:  J Ovarian Res       Date:  2020-10-01       Impact factor: 4.234

5.  HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells.

Authors:  Yu-Jie Dong; Wei Feng; Yan Li
Journal:  Front Cell Dev Biol       Date:  2021-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.